» Authors » Denis ODonnell

Denis ODonnell

Explore the profile of Denis ODonnell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 1489
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oyibo K, Gonzalez P, Ejaz S, Naheyan T, Beaton C, ODonnell D, et al.
JMIR Hum Factors . 2024 Mar; 11:e41557. PMID: 38512325
Background: Medication incidents (MIs) causing harm to patients have far-reaching consequences for patients, pharmacists, public health, business practice, and governance policy. Medication Incident Reporting and Learning Systems (MIRLS) have been...
2.
Aubert B, Barker J, Beaton C, Gonzalez P, Ghalambor-Dezfuli H, ODonnell D, et al.
Explor Res Clin Soc Pharm . 2023 Dec; 12:100379. PMID: 38145238
As the COVID-19 pandemic unfolded, community pharmacies adapted rapidly to broaden and adjust the services they were providing to patients, while coping with severe pressure on supply chains and constrained...
3.
Casaburi R, Merrill D, Leidy N, Locantore N, Dolmage T, Garcia-Aymerich J, et al.
Ann Am Thorac Soc . 2023 Dec; 21(5):727-739. PMID: 38109693
A COPD Foundation working group sought to identify measures of exercise endurance, a meaningful aspect of physical functioning in everyday life among patients with chronic obstructive pulmonary disease (COPD) that...
4.
Oostrik L, Bourbeau J, Doiron D, Ross B, Zhi-Li P, Aaron S, et al.
Chronic Obstr Pulm Dis . 2022 Dec; 10(1):89-101. PMID: 36563057
Background: The relationship between symptom burden and physical activity (PA) in chronic obstructive pulmonary disease (COPD) remains poorly understood with limited data on undiagnosed individuals and those with mild to...
5.
Casaburi R, Merrill D, Dolmage T, Garcia-Aymerich J, Fageras M, Goldstein R, et al.
Chronic Obstr Pulm Dis . 2022 Sep; 9(4):520-537. PMID: 36066494
Introduction: The COPD Biomarkers Qualification Consortium (CBQC) was formed under COPD Foundation management, with the goal of qualifying biomarkers and clinical outcome assessments through established regulatory processes for chronic obstructive...
6.
Bourbeau J, Doiron D, Biswas S, Smith B, Benedetti A, Brook J, et al.
Am J Respir Crit Care Med . 2022 Apr; 206(1):44-55. PMID: 35380941
Outdoor air pollution is a potential risk factor for lower lung function and chronic obstructive pulmonary disease (COPD). Little is known about how airway abnormalities and lung growth might modify...
7.
Celli B, Fabbri L, Aaron S, Agusti A, Brook R, Criner G, et al.
Am J Respir Crit Care Med . 2021 Sep; 204(11):1251-1258. PMID: 34570991
No abstract available.
8.
Chan A, ODonnell D, Kaasa B, Mathers A, Papaioannou A, Brazil K, et al.
Can Pharm J (Ott) . 2021 Apr; 154(2):100-109. PMID: 33868521
Background: Fifty percent of antibiotic courses in long-term care facilities (LTCFs) are unnecessary, leading to increased risk of harm. Most studies to improve antibiotic prescribing in LTCFs showed modest and...
9.
Leung C, Bourbeau J, Sin D, Aaron S, FitzGerald J, Maltais F, et al.
Int J Chron Obstruct Pulmon Dis . 2021 Feb; 16:305-320. PMID: 33603357
Purpose: To determine the spirometric-based prevalence of COPD across different regions in Canada and to evaluate the site heterogeneity of risk factors. Patients And Methods: In this cross-sectional, population-based study,...
10.
Ora J, Rogliani P, Dauri M, ODonnell D
Respir Res . 2021 Jan; 22(1):4. PMID: 33407457
Happy hypoxemia is an unspecified definition that is used in COVID-19 patients to define hypoxemia without dyspnoea. Dyspnoea is a very complex symptom, and although hypoxemia can cause breathlessness, dyspnoea...